The tumor-infiltrating RORC-Tregs we have shown to be linked to poor patient outcomes and associated with tumor androgenesis were selected based on elevated levels of FOXP3, CTLA4, GITR, RORC and GATA3 transcripts in the whole tumor, not from individual T-cells. Here, CTLA4 is linked to neoplasm.